Novo Nordisk Investigational Site
Copenhagen, 2400, Denmark
NCT Number: NCT01024218
This trial is conducted in Europe. The aim of this clinical trial is to assess the preference of 2 different needles used by nurses and health assistants. The trial consists of a handling test followed by a 12 week cross-over study.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 4
Copenhagen, 2400, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: after 12 weeks
Novo Nordisk A/S
Industry
An Open-label, Multicenter, Handling Test and Prospective Cross-over Study on Nurse/Health Assistants Preference Between NovoFine® Autocover™ and 8 mm NovoFine® Needle
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00121355
Delivery Systems, Diabetes
Plainsboro, New Jersey, United States
View Trial DetailsNCT00872560
Autoimmune Diseases, Delivery Systems
Chieti, Italy
View Trial DetailsNCT00773279
Autoimmune Diseases, Delivery Systems
Burlingame, California, United States
View Trial DetailsNCT01680328
Autoimmune Diseases, Delivery Systems
Neuss, Germany
View Trial Details